International Journal of Tuberculosis and Lung Disease

(The TQCC of International Journal of Tuberculosis and Lung Disease is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 500 papers]. The publications cover those that have been published in the past four years, i.e., from 2019-10-01 to 2023-10-01.)
The impact of COVID-19 on TB: a review of the data121
The GOLD Summit on chronic obstructive pulmonary disease in low- and middle-income countries79
Post-tuberculosis lung health: perspectives from the First International Symposium76
Effect of chronic obstructive pulmonary disease and smoking on the outcome of COVID-1967
The impact of alcohol use on tuberculosis treatment outcomes: a systematic review and meta-analysis45
Clinical standards for the assessment, management and rehabilitation of post-TB lung disease45
New diseases and old threats: lessons from tuberculosis for the COVID-19 response37
COVID-19 and tuberculosis—threats and opportunities36
Impact of COVID-19 on tuberculosis control in China32
Impact of COVID-19 on TB diagnosis in Northeastern Brazil32
Impact of COVID-19 on TB care: experiences of a treatment centre in Nigeria29
Impact of the COVID-19 pandemic on the detection of TB in Shanghai, China29
Mask wearing to complement social distancing and save lives during COVID-1928
Air pollution interventions and respiratory health: a systematic review26
Reduction of diagnostic and treatment delays reduces rifampicin-resistant tuberculosis mortality in Rwanda24
Clinical and economic impact of medication non-adherence in drug-susceptible tuberculosis: a systematic review23
The impact of smoking on tuberculosis treatment outcomes: a meta-analysis23
Post-tuberculosis sequelae: the need to look beyond treatment outcome22
Tuberculosis contact investigation and short-course preventive therapy among young children in Africa22
A partially randomised trial of pretomanid, moxifloxacin and pyrazinamide for pulmonary TB22
Tobacco control in China and the road to Healthy China 203021
Should we consider a ‘fourth 90’ for tuberculosis?20
Functional impact of sequelae in drug-susceptible and multidrug-resistant tuberculosis20
Severe COVID-19 cases with a history of active or latent tuberculosis19
Diagnosing pulmonary aspergillosis is much easier than it used to be: a new diagnostic landscape19
A decrease in tuberculosis evaluations and diagnoses during the COVID-19 pandemic19
Clinical standards for the diagnosis, treatment and prevention of TB infection19
How TB and COVID-19 compare: an opportunity to integrate both control programmes18
Impact of COVID-19 on tuberculosis services in India18
Occupational asthma18
Interventions to reduce losses in the cascade of care for latent tuberculosis: a systematic review and meta-analysis18
The need for pulmonary rehabilitation following tuberculosis treatment18
Impact of the global COVID-19 outbreak on the management of other communicable diseases18
The Global Asthma Report 202218
Acceptability of a first-line anti-tuberculosis formulation for children: qualitative data from the SHINE trial17
Thrombotic events and COVID-19 vaccines17
Critical changes to services for TB patients during the COVID-19 pandemic17
TB and COVID-19 co-infection: rationale and aims of a global study17
The COVID-19 and TB syndemic: the way forward17
Adapting TB services during the COVID-19 pandemic in Mumbai, India17
Treatment outcomes in patients with drug-resistant TB-HIV co-infection treated with bedaquiline and linezolid16
Household air pollution and COPD: cause and effect or confounding by other aspects of poverty?16
Resource reprioritisation amid competing health risks for TB and COVID-1915
Asbestos-related diseases15
Persistent chronic respiratory symptoms despite TB cure is poorly correlated with lung function15
Linezolid for the treatment of extensively drug-resistant tuberculosis: a systematic review and meta-analysis14
Clinical standards for the dosing and management of TB drugs13
Availability of diagnostic services and essential medicines for non‐communicable respiratory diseases in African countries13
Computer-aided detection for tuberculosis and silicosis in chest radiographs of gold miners of South Africa13
Impact of shelter-in-place on TB case notifications and mortality during the COVID-19 pandemic13
Pulmonary TB and chronic pulmonary aspergillosis: clinical differences and similarities13
Comparative analysis of Truenat™ MTB Plus and Xpert® Ultra in diagnosing tuberculous meningitis13
TB and the COVID-19 pandemic: brothers in arms against lung health13
Mortality due to TB-COVID-19 coinfection in India13
Multidrug-resistant tuberculosis in the Kharkiv Region, Ukraine12
National population-based tuberculosis prevalence survey in Ghana, 201312
Evaluation of recorded video-observed therapy for anti-tuberculosis treatment12
Implementing novel regimens for drug-resistant TB in South Africa: what can the world learn?12
The burden and determinants of post-TB lung disease12
Tuberculosis from transmission in clinics in high HIV settings may be far higher than contact data suggest12
Diabetes and body mass index in relation to risk of active tuberculosis: a prospective population-based cohort12
A global update on rare non-tuberculous mycobacteria in humans: epidemiology and emergence12
How to demystify COVID-19 and reduce social stigma12
Bedaquiline for multidrug-resistant TB in paediatric patients11
Delays and barriers to early treatment initiation for childhood tuberculosis in India11
TB multimorbidity: a global health challenge demanding urgent attention11
WHO drug-resistant TB guidelines 2022: what is new?11
Automated chest radiography and mass systematic screening for tuberculosis11
Let us not forget the mask in our attempts to stall the spread of COVID-1911
Tackling the threat of COVID-19 in Africa: an urgent need for practical planning11
Non-hospitalised COVID-19 patients have more frequent long COVID-19 symptoms11
Person-centred care in TB11
Managing multidrug-resistant tuberculosis in South Africa: a budget impact analysis10
Policies, practices and barriers to implementing tuberculosis preventive treatment—35 countries, 201710
Mycobacterium bovis in humans and M. tuberculosis in animals in Nigeria: an overview from 1975–201410
Sustaining essential healthcare in Africa during the COVID-19 pandemic10
Bedaquiline and delamanid result in low rates of unfavourable outcomes among TB patients in Eswatini10
The impact of COVID-19 on the diagnosis of TB in Taiwan10
Ototoxicity among multidrug-resistant TB patients: a systematic review and meta-analysis10
Identifying latent tuberculosis in high-risk populations: systematic review and meta-analysis of test accuracy9
Patient-cost survey for tuberculosis in the context of patient-pathway modelling9
Cost of tuberculosis treatment in low- and middle-income countries: systematic review and meta-regression9
Evidence for pulmonary rehabilitation in chronic respiratory diseases in sub-Saharan Africa: a systematic review9
Evaluating the use of educational videos to support the tuberculosis care cascade in remote Madagascar9
Geographic distribution, socio-economic disparity and policy determinants of smoke-free policy adoption in Indonesia9
Anthropogenic climate change and health in the Global South9
Predictive models for COVID-19-related deaths and infections9
Risk of hearing loss among multidrug-resistant tuberculosis patients according to cumulative aminoglycoside dose9
Management of rifampicin‐resistant TB: programme indicators and care cascade analysis in South Africa9
A systematic review and meta-analysis of first-line tuberculosis drug concentrations and treatment outcomes9
Serology-positive but minimally symptomatic COVID-19 may still cause lung injury and lung function impairment9
Evaluation of MTBDRsl for detecting resistance in Mycobacterium tuberculosis to second-line drugs9
How to manage children if a second wave of COVID-19 occurs9
The fourth national anti-tuberculosis drug resistance survey in Peru9
Risk factors for chronic pulmonary aspergillosis in post-TB patients9
First-line tuberculosis treatment with double-dose rifampicin is well tolerated8
Treatment outcomes and predictive factors for multidrug-resistant TB and HIV coinfection in Rio de Janeiro State, Brazil8
Two parallel pandemics: the challenges faced by countries with COVID-19 and TB8
Genomic diversity and transmission dynamics of M. tuberculosis in Africa: a systematic review and meta-analysis8
A comparison of digital chest radiography and Xpert® MTB/RIF in active case finding for tuberculosis8
Breastfeeding in women living with tuberculosis8
Smoking and HIV associated with subclinical tuberculosis: analysis of a population-based prevalence survey8
Latent tuberculosis infection and the EndTB Strategy: ethical tensions and imperatives8
Post-TB health and wellbeing8
COPD exacerbation rates are higher in non-smoker patients in India8
Pretomanid with bedaquiline and linezolid for drug-resistant TB: a comparison of prospective cohorts8
New TB drugs for the treatment of children and adolescents with rifampicin-resistant TB in Mumbai, India8
First molecular-based anti-TB drug resistance survey in Eritrea8
Real-world implementation of video-observed therapy in an urban TB program in the United States8
Multidisciplinary advisory teams to manage multidrug-resistant tuberculosis: the example of the French Consilium8
Effect of tablet crushing on drug exposure in the treatment of multidrug-resistant tuberculosis8
Preparing national tuberculosis control programmes for COVID-198
Mobile community-based active case-finding for tuberculosis among older populations in rural Cambodia8
Performance of a household tuberculosis exposure survey among children in a Latin American setting8
Priorities among HIV-positive individuals for tuberculosis preventive therapies8
The impact of PM2.5 on lung function in adults with asthma8
Determining the value of TB active case-finding: current evidence and methodological considerations8
Chronic obstructive pulmonary disease in sub-Saharan Africa7
Monitoring the COVID-19 pandemic in sub-Saharan Africa: focusing on health facility admissions and deaths7
Spatial variability in the risk of death from COVID-19 in Italy7
Determinants of lung health across the life course in sub-Saharan Africa7
Minimal clinically important difference of the 6-min walking test in patients with asthma7
Evaluation of a lateral-flow nanoparticle fluorescence assay for TB infection diagnosis7
What is the best culture conversion prognostic marker for patients treated for multidrug-resistant tuberculosis?7
Gaps in TB preventive therapy for persons initiating antiretroviral therapy in Uganda: an explanatory sequential cascade analysis7
Monocyte-to-lymphocyte ratio as a predictor of TB among people living with HIV7
Linezolid use for drug-resistant tuberculosis in Georgia: a retrospective cohort study7
Multidrug-resistant tuberculosis in the United States, 2011–2016: patient characteristics and risk factors7
Four of five tuberculosis patients experience catastrophic costs related to TB diagnosis and care in Timor-Leste7
Geographic distribution of chronic obstructive pulmonary disease prevalence in Africa, Asia and Australasia7
Cost of TB services in healthcare facilities in Kenya (No 3)7
Tuberculosis patients with higher levels of poverty face equal or greater costs of illness7
Modelling the potential impact of adherence technologies on tuberculosis in India7
The largest prison outbreak of TB in Western Europe investigated using whole-genome sequencing7
Number needed to screen for TB in clinical, structural or occupational risk groups7
The catastrophic cost of tuberculosis: advancing research and solutions7
Respiratory health among office workers in Malaysia and endotoxin and (1,3)-β-glucan in office dust6
A novel approach for eliciting adolescent MDR-TB treatment tolerability: qualitative data from South Africa6
Air conditioners, airborne infection prevention and air pollution in buildings in New Delhi6
Vitamin D status and latent tuberculosis infection: conversion in nursing homes, Spain6
Vitamin D deficiency is associated with tuberculosis disease in British children6
Diurnal variability of fine-particulate pollution concentrations: data from 14 low- and middle-income countries6
Opportunities to improve digital adherence technologies and TB care using human-centered design6
Impact of COVID-19 on patients with asthma6
TB and TB-HIV care for adolescents and young adults6
The scientific response to TB – the other deadly global health emergency6
Challenges in conducting trials for pediatric tuberculous meningitis: lessons from the field6
An Inca trail to the Holy Grail: digital medication adherence support for TB care6
Costs of TB services in India (No 1)6
High yields from contact investigation of child index TB patients6
Cost savings associated with video directly observed therapy for treatment of tuberculosis6
Unhealthy alcohol use independently associated with unfavorable TB treatment outcomes among Indian men6
Detection of Mycobacterium tuberculosis cell-free DNA to diagnose TB in pediatric and adult patients6
Estimation of subnational tuberculosis burden: generation and application of a new tool in Indonesia6
Cost of TB services in the public and private sectors in Georgia (No 2)5
Continuity of TB services during the COVID-19 pandemic in China5
Complications of tuberculous meningitis and their effect on outcome in a tertiary care cohort5
A randomised controlled trial to evaluate a medication monitoring system for TB treatment5
The 100th anniversary of bacille Calmette-Guérin (BCG) and the latest vaccines against COVID-195
Diagnostic yield of sputum induction in patients with pleural tuberculosis at a tertiary care hospital in Karachi5
QT prolongation in the STREAM Stage 1 Trial5
TB preventive treatment in high- and intermediate-incidence countries: research needs for scale-up5
Bacille Calmette-Guérin (BCG) vaccine and the COVID-19 pandemic: responsible stewardship is needed5
Face masks – a sustainable measure to mitigate COVID-195
Opportunities to prevent and manage undernutrition to amplify efforts to end TB5
COVID-19: ensuring continuity of TB services in the private sector5
The diagnosis of lung cancer in the era of interventional pulmonology5
Concern over a COVID-19-related BCG shortage5
Chronic respiratory disease in adult outpatients in three African countries: a cross-sectional study5
Effect of bronchial artery embolisation on the management of tuberculosis-related haemoptysis5
Sedimentation rate and suPAR in relation to disease activity and mortality in patients with tuberculosis5
Key changes in the public health response to TB and HIV in South Africa5
Improving access to affordable quality-assured inhaled medicines in low- and middle-income countries5
Characteristics of a “rebound” in smoking after a tobacco price increase5
The effect of systematic screening of the general population on TB case notification rates5
Costs of multidrug-resistant TB treatment in Finland and Estonia affected by the 2019 WHO guidelines5
Fluoroquinolone preventive therapy for children exposed to MDR-TB5
Acceptability of levofloxacin, moxifloxacin and linezolid among children and adolescents treated for TB5
Tuberculosis trends in a hot-spot region in Paris, France5
Rapid development of a portable negative pressure procedural tent5
Xpert® MTB/RIF Ultra performance in diagnosing paediatric pulmonary TB in gastric aspirates5
Clinical perspectives on treatment of rifampicin-resistant/multidrug-resistant TB5
Towards quality adolescent-friendly services in TB care5
Health-related quality of life associates with clinical parameters in patients with NTM pulmonary disease5
A systematic review of the number needed to screen for active TB among people living with HIV5
Vitamin D deficiency predicts latent TB reactivation independent of preventive therapy: a longitudinal study5
Measuring TB drug levels in the hair in adults and children to monitor drug exposure and outcomes5
Setting up pharmacovigilance based on available endTB Project data for bedaquiline5
Contribution of Xpert MTB/RIF to clinical diagnosis in adolescents with tuberculosis in Rio de Janeiro, Brazil4
Association between chronic airflow obstruction and socio-economic position in Morocco: BOLD results4
UNITE4TB: a new consortium for clinical drug and regimen development for TB4
A comparative analysis of asthma treatment guidelines and Essential Medicine Lists in sub-Saharan Africa4
Seasonality, climate change and tuberculosis: new data and old lessons4
The Bedaquiline Donation Program: progress and lessons learned after 4 years of implementation4
The war in Ukraine and potential consequences for the TB epidemic in Europe4
Therapeutic strategies and outcomes of MDR and pre-XDR-TB in Italy: a nationwide study4
Disseminated Mycobacterium avium complex infection as a differential diagnosis of tuberculosis in HIV patients4
COVID-19 and TB control in immigrant communities4
Quantification of neutrophil and monocyte CD64 expression: a predictive biomarker for active tuberculosis4
The impact of COVID-19 on the TB response: data from the field4
VIDAS® TB-IGRA reagents induce a CD4+ and CD8+ T-cell IFN-γ response for both TB infection and active TB4
Effects of comorbidities on quality of life in Filipino people with tuberculosis4
Helping Africa to breathe when COVID-19 strikes4
Adipokines and the risk of active TB: a nested case-control study4
Treatment outcomes in multidrug-resistant tuberculosis according to pyrazinamide susceptibility4
Decreased notification of TB cases during the COVID-19 pandemic4
Systematic rifampicin resistance errors with Xpert® MTB/RIF Ultra: implications for regulation of genotypic assays4
Preventive treatment of drug-resistant TB in a rural setting4
Density of cigarette retailers around educational facilities in Indonesia4
How Big Tobacco uses disruptive tactics to deny child rights to be tobacco-free4
Willingness to accept reimbursement for visits to an HIV clinic for tuberculosis preventive therapy4
Completion of treatment for latent TB infection in a low prevalence setting4
Chronic kidney disease, tuberculosis and climate change4
Seasonal drivers of tuberculosis: evidence from over 100 years of notifications in Cape Town4
Density of tobacco advertising around schools4
COVID-19 in Africa: community and digital technologies for tuberculosis management4
The Asthma Drug Facility and the future management of asthma4
Transforming essential services for tuberculosis during the COVID-19 pandemic: lessons from New York City4
Time for a change: considering regimen changes in analyses of observational drug-resistant TB treatment cohort data4
In Reply: How TB and COVID-19 compare: an opportunity to integrate both control programmes4
TB in older people in Asia: why it is important4
A positive COVID-19 test is associated with high mortality in RR-TB-HIV patients4
Clinical standards for drug-susceptible pulmonary TB4
Depression, stigma and quality of life in people with drug-susceptible TB and drug-resistant TB in Vietnam4
Impact of influenza A co-infection with COVID-194
How mechanistic in silico modelling can improve our understanding of TB disease and treatment4
Epidemiology, pathogenesis, clinical presentation and management of TB in patients with HIV and diabetes4
Using a mobile application to improve pediatric presumptive TB identification in western Kenya4
Effect of malnutrition on the pharmacokinetics of anti-TB drugs in Ghanaian children4
Is effective patient support missing in the global response to multidrug-resistant tuberculosis?4
Childhood TB in China: notification, characteristics and risk factors for outcomes, 2010–20174
Tuberculosis and diabetes mellitus: a dose-response relationship between the odds of tuberculosis and HbA1c4
Tobacco use and quitting behaviour during COVID-19 lockdown4
COVID-19 and TB: a progression-regression conundrum4
A public health approach to increase treatment of latent TB among household contacts in Brazil4
Knowledge, attitudes and practices on childhood TB among healthcare workers4
Factors associated with tuberculosis-associated haemophagocytic syndrome: a multicentre case-control study3
Epidemiology of tuberculosis among healthcare personnel in New York City3
Reasons why patients with tuberculosis in South Korea stop anti-TB treatment: a cross-sectional study3
Implementing 3HP vs. IPT as TB preventive treatment in Pakistan3
Increase in disseminated TB during the COVID‐19 pandemic3
Treatment success, but living with the consequences of post-tuberculosis sequelae3
Introduction of bedaquiline for the treatment of drug-resistant TB in the Philippines3
Using a geographic information system as a management tool for tuberculosis control3
Prevalence and risk factors of tuberculosis disease in South African correctional facilities in 20153
Leveraging differentiated HIV service delivery to expand tuberculosis preventive treatment: a call to action3
Impact of mental disorders on active TB treatment outcomes: a systematic review and meta-analysis3
Introducing new and repurposed TB drugs: the endTB experience3
Subclinical tuberculosis and adverse infant outcomes in pregnant women with HIV3
Acquired bedaquiline resistance in Karakalpakstan, Uzbekistan3
Effect of Global Fund financial support for patients with multidrug-resistant tuberculosis3
An assessment of current tuberculosis patient care and support policies in high-burden countries3
Tuberculosis surveillance in adolescents: what to learn from European Union/European Economic Area data?3
Strengthened capacity of India´s bedaquiline Conditional Access Programme for introducing new drugs and regimens3
Presentation and outcome of patients with intracranial tuberculoma in a high HIV prevalence setting3
TB testing in HIV-positive patients prior to antiretroviral treatment3
TB in children and adolescents3
Impact of the COVID-19 pandemic on TB infection testing3
How much does TB screening cost? A systematic review of economic evaluations3
Epidemiology and clinical characteristics of childhood TB identified using active and passive case finding3
Prevalence of and risk factors for depressive symptoms in non-tuberculous mycobacterial pulmonary disease3
Treatment outcomes and safety in children with rifampicin-resistant TB3
Community-based TB testing as an essential part of TB recovery plans in the COVID-19 era3
Work-related interstitial lung disease: what is the true burden?3
Diagnostic yield of active case finding for tuberculosis at human immunodeficiency virus testing in Haiti3
Clinical outcomes among patients with tuberculous meningitis receiving intensified treatment regimens3
Psychological distress among TB patients in sub-Saharan Africa3
Adapting a TB contact investigation strategy for COVID-193
How COVID-19 can instruct TB research: ensuring the safety of researchers exposed to infectious disease3
Pharmacokinetics of high-dose isoniazid in children affected by multidrug-resistant TB3
Planning for TB elimination in Lebanon3
Risk factors for the delayed diagnosis of extrapulmonary TB3
Distinctive patterns of pulmonary function change according to baseline lung volume and diffusing capacity3
Effect of 6-month vs. 8-month regimen on retreatment success for pulmonary TB3
Epidemiology and risk factors for extrapulmonary tuberculosis in Lebanon3
Post-TB bronchiectasis: from pathogenesis to rehabilitation3
Diagnostic code agreement for electronic health records and claims data for tuberculosis3
Country differences and determinants of yield in programmatic migrant TB screening in four European countries3
WHO target product profiles for TB preventive treatment3
Global Asthma Report 2022: a wake-up call to enhance care and treatment for asthma globally3
Impact of COVID-19 on TB services in Korea3
Screening for active and latent TB among migrants in France3
Engaging private pharmacies to help end TB in India3
Symptom and digital chest X-ray TB screening in South African prisons: yield and cost-effectiveness3
Ethambutol-induced optic neuropathy in nontuberculous mycobacterial disease3
Isoniazid and verapamil modulatory activity and efflux pump gene expression in Mycobacterium tuberculosis3
Reference values of impulse oscillometry (IOS) for healthy Indian adults3
Determinants of treatment outcomes in patients with multidrug-resistant TB3
Undernutrition can no longer be an afterthought for global efforts to eliminate TB3
Patterns of suboptimal adherence among adolescents treated for tuberculosis3
What to look for when using SUBsET for subnational TB incidence estimates3
Incremental yield of Xpert® MTB/RIF Ultra over Xpert® MTB/RIF in the diagnosis of extrapulmonary TB3
Fluorescein diacetate and rapid molecular testing for the early identification of rifampicin resistance in Mali3
Changes to TB care in an outpatient centre during the COVID‐19 pandemic3
National survey on the impact of the war in Ukraine on TB diagnostics and treatment services in 20223
TB outcomes and mortality risk factors in adult migrants at the Thailand-Myanmar border3
Impact of lung function on treatment outcome in patients with TB3
Associations between air pollutants and peak expiratory flow and fractional exhaled nitric oxide in students3